Alembic Q2 net profit falls 49% to Rs 169 crore; gets observations from USFDA for Karkhadi facility

The company had posted a net profit of Rs 333.37 crore for the corresponding period of the previous fiscal, Alembic Pharmaceuticals said in a regulatory filing. Its consolidated revenue from operations during July-September 2021 stood at Rs 1,292.32 crore. It was Rs 1,457.10 crore in the corresponding period a year ago, it added.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3D3MLpo
via IFTTT